´ëÇÑÆó¾ÏÇÐȸ (ÇÏÀ̺긮µå)2022 KALC International Conference-2ÀÏÂ÷ : 2022-11-11±³À°ÀÏÀÚ : 2022-11-11
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ¿ùµå Å©¸®½ºÅ»·ë(ÇÏÀ̺긮µå Çмú´ëȸ)
±³À°ÁÖÁ¦ :
(ÇÏÀ̺긮µå)2022 KALC International Conference-2ÀÏÂ÷ÁÖÃÖ±â°ü : ´ëÇÑÆó¾ÏÇÐȸ
´ã´çÀÚ : ±èÀÎÁ¤
¿¬¶ôó : 02-741-8540
À̸ÞÀÏ :
kalc@lungca.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 110,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 07:50~08:40 How to Interpret the Results of Japan Clinical Oncology Group 0802 Study, a Comparison between Lobectomy and Segmentectomy for the Peripheral Non-Small Cell Lung Cancer Hisao Asamura(Keio Univ., Japan)
ÈÞ½Ä 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 08:40~08:50 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 08:50~09:20 Implementation of Population Based Lung Cancer Screening in Europe John K. Field(The Univ. of Liverpool, UK)
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 09:20~09:45 Lung Cancer Screening in Never-Smokers Ryutaro Kakinuma(National Cancer Center, Japan)
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 09:45~10:10 Functional Genomics Approaches to Understand Genetic Susceptibility to Lung Cancer Jiyeon Choi(National Cancer Institute, USA)
ÈÞ½Ä 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 10:10~10:30 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 10:30~10:50 Radiologic Characteristics of Multiple Primary Lung Cancer Including Ground Glass Nodules Geewon Lee(Pusan National Univ)
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 10:50~11:10 Pathologic Differentiation and Significance of Next-Generation Sequencing for Synchronous or Metachronous Lesions vs Metastatic or Recurred Lesions in Lung Cancer Jin-Haeng Chung(Seoul National Univ)
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 11:10~11:30 Surgical Strategy for Multiple Primary Lung Cancer Alan D. L. Sihoe(Gleneagles Hong Kong Hospital, Hong Kong)
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 11:30~11:50 Recent Advances in Radiotherapy for Multiple Primary Lung Cancer Si Yeol Song(Univ. of Ulsan)
ÈÞ½Ä 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 11:50~12:00 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 12:00~12:40 Paradigm-Leading Therapeutic Strategy for Early Stage of Lung Cancer Patients Alan D. L. Sihoe(Gleneagles Hong Kong Hospital, Hong Kong)
ÈÞ½Ä 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 12:40~13:00 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 13:00~13:40 Progress Towards Non-Small Cell Lung Cancer Models that Represent Clinical Evolutionary Trajectories Robert E. Hynds(Univ. College London, UK)
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 13:40~14:10 A Minimal Sufficient Condition for the Development of K-Ras-Activated Lung Cancer Suk-Chul Bae(Chungbuk National Univ)
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 14:10~14:40 Development of a Novel Mouse Model for Improved Evaluation of in vivo Anti-Cancer Effects: Targeted Therapy and Immunotherapy Jin Kyung Rho(Univ. of Ulsan)
ÈÞ½Ä 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 14:40~15:00 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 15:00~15:30 Clinical Application of Natural Killer T Cells to Cancer Immunotherapy Shinichiro Motohashi(Chiba Univ., Japan)
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 15:30~16:00 Natural Killer Cell-Based Cancer Immune Cell Therapy Paul Y. Song(NKgene Biotec, USA)
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 16:00~16:40 Engineered Canner Immune Cell Therapy (CAR-T Cell Therapy) Hun Ju Lee(UT MD Anderson Cancer Center,USA)
ÈÞ½Ä 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 16:40~16:50 ÈÞ½Ä ()
±³À°½Ã°£ 11-11 ·Ôµ¥È£ÅÚ ¿ùµå Å©¸®½ºÅ»º¼·ë 16:50~17:40 The Evolving Treatment Landscape of ALK+Non-Small Cell Lung Cancer with Lorlatinib Sehhoon Park(Sungkyunkwan Univ)